| Literature DB >> 31857825 |
Fahad D Alosaimi1,2, Reem Labani3, Nouf Almasoud3, Nora Alhelali3, Lamya Althawadi3, Dhaherah Mani AlJahani3.
Abstract
BACKGROUND: Patients with diabetic foot ulcers may have a lower quality of life. The objective was to compare the quality of life and its psychosocial determinants among patients with and without diabetic foot ulcers.Entities:
Keywords: Anxiety; Depression; Diabetic foot; Quality of life; Saudi Arabia
Mesh:
Year: 2019 PMID: 31857825 PMCID: PMC6905071 DOI: 10.1186/s13047-019-0367-5
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Demographic characteristics of 209 Saudi diabetic patients by diabetic foot ulcer statusa
| Diabetic foot ulcers | Total ( | Magnitude of difference b | |||
|---|---|---|---|---|---|
| Yes ( | No ( | ||||
| Age (years) | |||||
| Mean ± SD | 56.7 ± 12.3 | 56.1 ± 11.6 | 56.2 ± 11.7 | 0.7 (−3.3–4.6) | 0.740 |
| < 60 | 24 (54.5%) | 99 (61.5%) | 123 (60.0%) | – | 0.405 |
| ≥ 60 | 20 (45.5%) | 62 (38.5%) | 82 (40.0%) | 1.36 (0.69–2.66) | |
| Weight (kg) | 88.8 ± 20.4 | 82.2 ± 20.2 | 83.6 ± 20.4 | 6.6 (−1.1–14.3) | 0.091 |
| Height (cm) | 165.4 ± 8.7 | 161.8 ± 8.8 | 162.6 ± 8.9 | 3.6 (0.2–7.0) | 0.037 |
| Body mass index | |||||
| Mean ± SD | 32.7 ± 7.8 | 31.7 ± 7.6 | 31.9 ± 7.6 | 1.0 (−2.0–4.0) | 0.509 |
| Normal | 4 (12.1%) | 19 (16.5%) | 23 (15.5%) | – | 0.743 |
| Overweight | 11 (33.3%) | 32 (27.8%) | 43 (29.1%) | 1.72 (0.48–6.14) | |
| Obese | 18 (54.5%) | 64 (55.7%) | 82 (55.4%) | 1.41 (0.43–4.64) | |
| Gender | |||||
| Male | 23 (51.1%) | 70 (42.7%) | 93 (44.5%) | 1.43 (0.74–2.78) | 0.314 |
| Female | 22 (48.9%) | 94 (57.3%) | 116 (55.5%) | – | |
| Marital status | |||||
| Single | 3 (6.7%) | 7 (4.3%) | 10 (4.8%) | – | 0.197 |
| Married | 33 (73.3%) | 132 (80.5%) | 165 (78.9%) | 0.75 (0.19–2.93) | |
| Widow | 5 (11.1%) | 21 (12.8%) | 26 (12.4%) | 0.71 (0.14–3.65) | |
| Divorced | 4 (8.9%) | 4 (2.4%) | 8 (3.8%) | 3.0 (0.45–20.15) | |
| Educational level | |||||
| Illiterate | 7 (16.3%) | 34 (21.4%) | 41 (20.3%) | – | 0.407 |
| Less than high school | 17 (39.5%) | 43 (27.0%) | 60 (29.7%) | 1.92 (0.72–5.16) | |
| High school | 10 (23.3%) | 37 (23.3%) | 47 (23.3%) | 1.31 (0.45–3.84) | |
| University or above | 9 (20.9%) | 45 (28.3%) | 54 (26.7%) | 0.97 (0.33–2.87) | |
| Occupation | |||||
| Field job | 3 (6.7%) | 15 (9.1%) | 18 (8.6%) | 0.79 (0.21–3.02) | 0.651 |
| Office job | 9 (20.0%) | 21 (12.8%) | 30 (14.4%) | 1.69 (0.66–4.31) | |
| Housewife | 15 (33.3%) | 57 (34.8%) | 72 (34.4%) | 1.04 (0.48–2.24) | |
| Not working | 18 (40.0%) | 71 (43.3%) | 89 (42.6%) | – | |
| Monthly family income (SR) | |||||
| < 5000 | 20 (47.6%) | 55 (36.2%) | 75 (38.7%) | – | 0.172 |
| 5000-9999 | 12 (28.6%) | 48 (31.6%) | 60 (30.9%) | 0.69 (0.31–1.55) | |
| 10,000-14,999 | 8 (19.0%) | 23 (15.1%) | 31 (16.0%) | 0.96 (0.37–2.48) | |
| ≥ 15,000 | 2 (4.8%) | 26 (17.1%) | 28 (14.4%) | 0.21 (0.05–0.97) | |
| Number of family members | |||||
| Mean ± SD | 6.8 ± 3.1 | 7.0 ± 3.4 | 7.0 ± 3.3 | −0.2 (−1.4–0.9) | 0.718 |
| Living alone | |||||
| No | 39 (86.7%) | 143 (88.3%) | 182 (87.9%) | – | 0.770 |
| Yes | 6 (13.3%) | 19 (11.7%) | 25 (12.1%) | 1.16 (0.43–3.10) | |
a Number (frequency) unless noted otherwise; SD standard deviation. b Magnitude of difference between cases and control; odds ratio (for categorical data) or mean difference (for continuous data) plus 95% confidence interval. Empty cells means reference group
Clinical characteristics of 209 Saudi diabetic patients by diabetic foot ulcer statusa
| Diabetic foot ulcers | Total ( | Magnitude of difference b | |||
|---|---|---|---|---|---|
| Yes ( | No ( | ||||
| Type of diabetes | |||||
| Type 1 | 4 (8.9%) | 33 (20.1%) | 37 (17.7%) | 0.21 (0.06–0.75) | 0.033 |
| Type 2 | 29 (64.4%) | 110 (67.1%) | 139 (66.5%) | 0.46 (0.20–1.05) | |
| Unknown | 12 (26.7%) | 21 (12.8%) | 33 (15.8%) | – | |
| HbA1c | |||||
| Mean ± SD | 9.9 ± 2.7 | 8.4 ± 2.0 | 8.6 ± 2.2 | 1.5 (0.3–2.7) | 0.016 |
| ≥ 8 | 18 (78.3%) | 53 (54.1%) | 71 (58.7%) | 3.06 (1.05–8.89) | 0.034 |
| < 8 | 5 (21.7%) | 45 (45.9%) | 50 (41.3%) | – | |
| Age at diagnosis of diabetes | 37.6 ± 12.0 | 42.7 ± 12.0 | 41.6 ± 12.1 | −5.1 (−9.1--1.1) | 0.014 |
| Family history of diabetes | |||||
| No | 14 (31.1%) | 46 (28.0%) | 60 (28.7%) | – | 0.688 |
| Yes | 31 (68.9%) | 118 (72.0%) | 149 (71.3%) | 0.86 (0.42–1.77) | |
| Symptoms | |||||
| Peripheral tingling | 23 (52.3%) | 68 (42.5%) | 91 (44.6%) | 1.48 (0.76–2.89) | 0.248 |
| Peripheral numbness | 35 (79.5%) | 78 (48.8%) | 113 (55.4%) | 4.09 (1.85–9.06) | < 0.001 |
| Peripheral hypo- or hyperthermia | 20 (45.5%) | 70 (43.8%) | 90 (44.1%) | 1.07 (0.55–2.10) | 0.840 |
| Peripheral painlessness | 17 (38.6%) | 16 (10.0%) | 33 (16.2%) | 5.67 (2.55–12.57) | < 0.001 |
| Peripheral edema | 10 (22.7%) | 39 (24.4%) | 49 (24.0%) | 0.91 (0.41–2.02) | 0.821 |
| Tiredness without working | 15 (34.1%) | 80 (50.0%) | 95 (46.6%) | 0.52 (0.26–1.04) | 0.061 |
| Blurred vision | 20 (45.5%) | 54 (33.8%) | 74 (36.3%) | 1.64 (0.83–3.22) | 0.153 |
| Nocturnal dyspnea | 4 (9.1%) | 27 (16.9%) | 31 (15.2%) | 0.49 (0.16–1.49) | 0.203 |
| Loss of concentration | 13 (29.5%) | 35 (21.9%) | 48 (23.5%) | 1.50 (0.71–3.17) | 0.288 |
| Amputation | 10 (22.7%) | 0 (0.0%) | 10 (4.9%) | NA | < 0.001 |
| Number of comorbid diseases | |||||
| Mean ± SD | 2.9 ± 1.9 | 2.8 ± 2.0 | 2.8 ± 2.0 | 0.1 (−0.5–0.8) | 0.702 |
| None | 5 (11.1%) | 19 (11.7%) | 24 (11.5%) | – | 0.715 |
| One or two | 16 (35.6%) | 68 (41.7%) | 84 (40.4%) | 0.89 (0.29–2.76) | |
| Three or more | 24 (53.3%) | 76 (46.6%) | 100 (48.1%) | 1.20 (0.41–3.56) | |
| Comorbidity | |||||
| Hypercholesterolemia | 20 (44.4%) | 97 (59.5%) | 117 (56.3%) | 0.54 (0.28–1.06) | 0.071 |
| Hypertension | 28 (62.2%) | 76 (46.6%) | 104 (50.0%) | 1.89 (0.96–3.71) | 0.064 |
| Joint diseases | 10 (22.2%) | 61 (37.4%) | 71 (34.1%) | 0.48 (0.22–1.03) | 0.057 |
| Cataracts | 11 (24.4%) | 32 (19.6%) | 43 (20.7%) | 1.32 (0.61–2.90) | 0.480 |
| Cardiovascular diseases | 12 (26.7%) | 29 (17.8%) | 41 (19.7%) | 1.68 (0.78–3.64) | 0.185 |
| Retinal disease | 14 (31.1%) | 20 (12.3%) | 34 (16.3%) | 3.23 (1.47–7.08) | 0.002 |
| Gastrointestinal disease | 5 (11.1%) | 26 (16.0%) | 31 (14.9%) | 0.66 (0.24–1.83) | 0.420 |
| Lung disease | 5 (11.1%) | 24 (14.7%) | 29 (13.9%) | 0.72 (0.26–2.02) | 0.536 |
| Anemia | 4 (8.9%) | 25 (15.3%) | 29 (13.9%) | 0.54 (0.18–1.64) | 0.269 |
| Renal disease | 4 (8.9%) | 15 (9.2%) | 19 (9.1%) | 0.96 (0.30–3.06) | > 0.99 |
| Others | 14 (31.1%) | 34 (20.9%) | 48 (23.1%) | 2.14 (0.68–6.74) | 0.148 |
a Number (frequency) unless noted otherwise; SD standard deviation. b Magnitude of difference between cases and control; odds ratio (for categorical data) or mean difference (for continuous data) plus 95% confidence interval. Empty cells means reference group; NA, difference cannot be calculated
Psychological characteristics and psychosocial examination results of 209 Saudi diabetic patients by diabetic foot ulcer statusa
| Diabetic foot ulcers | Total ( | Magnitude of difference b | |||
|---|---|---|---|---|---|
| Yes ( | No ( | ||||
| Family history of psychiatric illness | |||||
| No | 36 (90.0%) | 141 (88.1%) | 177 (88.5%) | – | > 0.99 |
| Yes | 4 (10.0%) | 19 (11.9%) | 23 (11.5%) | 0.83 (0.26–2.58) | |
| Visit to psychiatrist | |||||
| No | 33 (75.0%) | 149 (90.9%) | 182 (87.5%) | – | 0.005 |
| Yes | 11 (25.0%) | 15 (9.1%) | 26 (12.5%) | 3.31 (1.40–7.86) | |
| Psychological/behavioral therapy | |||||
| No | 33 (82.5%) | 149 (93.1%) | 182 (91.0%) | – | 0.058 |
| Yes | 7 (17.5%) | 11 (6.9%) | 18 (9.0%) | 2.87 (1.04–7.97) | |
| Psychiatric medications | |||||
| No | 30 (75.0%) | 148 (93.1%) | 178 (89.4%) | – | 0.002 |
| Yes | 10 (25.0%) | 11 (6.9%) | 21 (10.6%) | 4.49 (1.75–11.50) | |
| Social support from family or friends | |||||
| No | 10 (25.0%) | 33 (20.8%) | 43 (21.6%) | – | 0.062 |
| Yes | 29 (72.5%) | 99 (62.3%) | 128 (64.3%) | 0.97 (0.43–2.19) | |
| Somewhat | 1 (2.5%) | 27 (17.0%) | 28 (14.1%) | 0.12 (0.02–1.02) | |
| Psychological deterioration after diagnosis of diabetes | |||||
| No | 21 (52.5%) | 93 (58.1%) | 114 (57.0%) | – | 0.771 |
| Yes | 10 (25.0%) | 38 (23.8%) | 48 (24.0%) | 1.17 (0.50–2.71) | |
| Somewhat | 9 (22.5%) | 29 (18.1%) | 38 (19.0%) | 1.37 (0.57–3.33) | |
| Improved family relationship after diagnosis of diabetes | |||||
| No | 9 (22.5%) | 54 (33.8%) | 63 (31.5%) | – | 0.216 |
| Yes | 23 (57.5%) | 68 (42.5%) | 91 (45.5%) | 2.03 (0.87–4.75) | |
| Somewhat | 8 (20.0%) | 38 (23.8%) | 46 (23.0%) | 1.26 (0.45–3.57) | |
| Quality of life; WHOQOL-BREF (mean ± SD) | |||||
| Domain 1: Physical health | 67.1 ± 19.2 | 71.1 ± 16.4 | 70.2 ± 17.1 | −4.0 (−9.7–1.7) | 0.263 |
| Domain 2: Psychological | 75.4 ± 14.9 | 78.0 ± 13.3 | 77.4 ± 13.7 | −2.6 (−7.1–2.0) | 0.384 |
| Domain 3: Social relationships | 77.3 ± 16.5 | 77.5 ± 17.5 | 77.4 ± 17.3 | −0.2 (−5.9–5.5) | 0.712 |
| Domain 4: Environment | 75.1 ± 16.7 | 74.7 ± 13.8 | 74.8 ± 14.5 | 0.4 (−4.4–5.2) | 0.672 |
| Overall quality of life and general health | 75.6 ± 13.2 | 75.1 ± 17.2 | 75.2 ± 16.4 | 0.4 (−5.0–5.9) | 0.891 |
| Total: All above domains | 73.2 ± 12.4 | 74.8 ± 12.0 | 74.4 ± 12.1 | −1.5 (− 5.5–2.5) | 0.539 |
| Anxiety; HAD anxiety | |||||
| Mean ± SD | 4.7 ± 4.6 | 4.1 ± 4.4 | 4.2 ± 4.5 | 0.6 (−0.9–2.1) | 0.355 |
| Normal 0–7 | 34 (75.6%) | 134 (81.7%) | 168 (80.4%) | – | 0.357 |
| Anxiety > 7 | 11 (24.4%) | 30 (18.3%) | 41 (19.6%) | 1.45 (0.66–3.17) | |
| Depression; HAD depression | |||||
| Mean ± SD | 5.7 ± 4.3 | 4.7 ± 3.7 | 4.9 ± 3.9 | 1.0 (−0.3–2.3) | 0.200 |
| Normal 0–7 | 30 (66.7%) | 127 (77.4%) | 157 (75.1%) | – | 0.139 |
| Depression > 7 | 15 (33.3%) | 37 (22.6%) | 52 (24.9%) | 1.72 (0.84–3.53) | |
| Somatic symptoms; PHQ-15 | |||||
| Mean ± SD | 6.8 ± 5.7 | 8.5 ± 6.2 | 8.1 ± 6.1 | −1.6 (−3.7–0.4) | 0.114 |
| Minimal severity (0–4) | 18 (40.0%) | 59 (36.0%) | 77 (36.8%) | – | 0.213 |
| Low severity (5–9) | 16 (35.6%) | 40 (24.4%) | 56 (26.8%) | 1.31 (0.60–2.87) | |
| Medium severity (10–14) | 7 (15.6%) | 33 (20.1%) | 40 (19.1%) | 0.70 (0.26–1.84) | |
| High severity (≥15) | 4 (8.9%) | 32 (19.5%) | 36 (17.2%) | 0.41 (0.13–1.32) | |
| Self-Management; SDSCA (mean ± SD) | |||||
| Diet | 44.8 ± 39.3 | 29.2 ± 36.9 | 32.6 ± 37.9 | 15.5 (3.1–28.0) | 0.011 |
| Exercise | 17.1 ± 26.1 | 18.7 ± 27.2 | 18.4 ± 26.9 | −1.6 (−10.5–7.4) | 0.351 |
| Blood sugar testing | 55.4 ± 37.9 | 36.1 ± 37.2 | 40.2 ± 38.1 | 19.3 (6.9–31.7) | 0.003 |
| Foot care | 50.8 ± 35.7 | 23.4 ± 33.7 | 29.2 ± 35.9 | 27.4 (16.0–38.8) | < 0.001 |
| Total | 42.2 ± 20.3 | 27.2 ± 21.2 | 30.4 ± 21.8 | 15.0 (8.0–22.0) | < 0.001 |
a Number (frequency) unless noted otherwise. Abbreviations: SD standard deviation, WHOQOL-BREF World Health Organization Quality of Life Assessment, HAD Hospital Anxiety and Depression scale, PHQ-15 the Patient Health Questionnaire Physical Symptoms; SDSCA Summary of Diabetes Self-Care Activities. b Magnitude of difference between cases and control; odds ratio (for categorical data) or mean difference (for continuous data) plus 95% confidence interval. Empty cells means reference group
Multivariate linear regression for the determinants of quality of life among 209 Saudi diabetic patients
| Unstandardized beta | Standard error of beta | 95% confidence interval (CI) | |||
|---|---|---|---|---|---|
| Lower CI | Upper CI | ||||
| Anxiety; HAD anxiety | −0.034 | 0.029 | −0.094 | 0.025 | 0.251 |
| Depression; HAD depression | −0.069 | 0.030 | −0.129 | −0.009 | 0.026 |
| Somatic symptoms; PHQ-15 | −0.046 | 0.037 | −0.120 | 0.029 | 0.224 |
| Self-management; SDSCA | 0.036 | 0.032 | −0.029 | 0.102 | 0.270 |
| Diabetic foot ulcer | 0.989 | 1.059 | 0.882 | 1.108 | 0.848 |
Abbreviations as listed in Table 3
Adjusted for age, gender, BMI, marital status, educational level, occupation, monthly income, number of family members, HBA1c level, and number of comorbid diseases
Correlations of quality of life with other psychosocial examination results and comorbidities of 209 Saudi diabetic patients by diabetic foot (DF) ulcer status
| Physical health | Psychological | Social relationships | Environment | Overall | Total (all domains) | |
|---|---|---|---|---|---|---|
| DM with DF | ||||||
| Anxiety; HAD anxiety | − 0.381** | − 0.363* | − 0.104 | − 0.396** | − 0.488** | − 0.494** |
| Depression; HAD depression | − 0.565** | − 0.512** | − 0.212 | − 0.453** | − 0.552** | − 0.624** |
| Somatic symptoms; PHQ-15 | −0.353* | − 0.179 | − 0.109 | − 0.321* | −0.197 | − 0.401** |
| Self-management; SDSCA | ||||||
| Diet | −0.133 | 0.243 | 0.070 | 0.049 | 0.441** | 0.065 |
| Exercise | 0.132 | −0.001 | 0.156 | 0.192 | 0.313* | 0.190 |
| Blood sugar testing | −0.159 | − 0.109 | − 0.095 | 0.118 | − 0.083 | − 0.085 |
| Foot care | 0.155 | 0.106 | −0.100 | 0.129 | 0.102 | 0.203 |
| Total | −0.010 | 0.139 | −0.021 | 0.189 | 0.334* | 0.161 |
| Number of comorbid diseases | 0.096 | 0.047 | −0.039 | − 0.065 | − 0.020 | − 0.018 |
| DM without DF | ||||||
| Anxiety; HAD anxiety | −0.562** | − 0.547** | − 0.350** | −0.362** | − 0.365** | −0.587** |
| Depression; HAD depression | −0.521** | −0.488** | − 0.411** | −0.385** | − 0.341** | −0.574** |
| Somatic symptoms; PHQ-15 | −0.654** | −0.462** | − 0.324** | −0.368** | − 0.352** | −0.582** |
| Self-management; SDSCA | ||||||
| Diet | 0.078 | 0.127 | 0.052 | 0.156* | 0.084 | 0.108 |
| Exercise | 0.226** | 0.005 | −0.043 | 0.073 | 0.034 | 0.109 |
| Blood sugar testing | −0.087 | −0.049 | 0.101 | −0.007 | − 0.033 | −0.064 |
| Foot care | 0.006 | 0.138 | 0.146 | 0.144 | 0.109 | 0.127 |
| Total | 0.036 | 0.080 | 0.059 | 0.111 | 0.057 | 0.068 |
| Number of comorbid diseases | −.411** | −0.149 | −0.120 | −0.106 | −0.086 | − 0.253** |
| Total | ||||||
| Anxiety; HAD anxiety | −0.525** | −0.509** | − 0.293** | −0.368** | − 0.387** | −0.559** |
| Depression; HAD depression | −0.534** | −0.491** | − 0.376** | −0.397** | − 0.382** | −0.582** |
| Somatic symptoms; PHQ-15 | −0.575** | −0.396** | − 0.274** | −0.358** | − 0.319** | −0.532** |
| Self-management; SDSCA | ||||||
| Diet | 0.016 | 0.135 | 0.038 | 0.127 | 0.148* | 0.084 |
| Exercise | 0.212** | 0.009 | 0.006 | 0.094 | 0.092 | 0.137* |
| Blood sugar testing | −0.118 | −0.065 | 0.050 | 0.024 | −0.046 | −0.073 |
| Foot care | −0.002 | 0.099 | 0.085 | 0.136 | 0.087 | 0.111 |
| Total | 0.010 | 0.073 | 0.048 | 0.140* | 0.095 | 0.079 |
| Number of comorbid diseases | −.300** | −0.105 | −0.106 | − 0.092 | −0.075 | − 0.201** |
Correlation is significant at the 0.05 level (*) or the 0.01 level (**). Abbreviations as listed in Table 3